Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery
RNA-based therapeutic approaches for coagulation factor deficiencies
External and internal validity of open label or double-blind trials in oral anticoagulation: better, worse or just different?
Comparison of enoxaparin and unfractionated heparin in endovascular interventions for the treatment of peripheral arterial occlusive disease: a randomized controlled trial
Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial
Concentrate-related inhibitor risk: is a difference always real?
Can B-domain deletion alter the immunogenicity of recombinant factor VIII? A meta-analysis of prospective clinical studies
The timing, extent, progression and regression of deep vein thrombosis in immobile stroke patients: observational data from the CLOTS multicenter randomized trials
The effects of cause of death classification on prognostic assessment of patients with pulmonary embolism
Long-term follow-up of patients with portal vein thrombosis and myeloproliferative neoplasms
Performance outcomes of a pharmacist-managed anticoagulation clinic in the rural, resource-constrained setting of Eldoret, Kenya
A functional variant in the thrombospondin-1 gene and the risk of small for gestational age infants
The use of a single von Willebrand factor-containing, plasma-derived FVIII product in hemophilia A immune tolerance induction: the US experience
Functional factor VIII made with von Willebrand factor at high levels in transgenic milk
Increased tissue factor pathway inhibitor activity is associated with myocardial infarction in young women: results from the RATIO study
Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability
Activated protein C inhibitor for correction of thrombin generation in hemophilia A blood and plasma
TAFIa inhibiting nanobodies as profibrinolytic tools and discovery of a new TAFIa conformation
Extracellular protein disulfide isomerase regulates feedback activation of platelet thrombin generation via modulation of coagulation factor binding
Genetic determinants of platelet reactivity during acetylsalicylic acid therapy in diabetic patients: evaluation of 27 polymorphisms within candidate genes
Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia
Not exclusively tissue factor: neutrophil extracellular traps provide another link between chemotherapy and thrombosis
Breast cancer chemotherapy induces the release of cell-free DNA, a novel procoagulant stimulus
Flow chamber-based assays to measure thrombus formation in vitro: requirements for standardization
Best evidence on B-domain deletion and the immunogenicity of recombinant factor VIII
Factor VIII inhibitors in previously treated hemophilic patients
Factor XII gene mutation in the Hageman family
Comparison of ‘time within therapeutic INR range’ with ‘percentage INR within therapeutic range’ for assessing long-term anticoagulation control in children: a rebuttal
Comparison of time within therapeutic INR range with percentage INR within therapeutic range for assessing long-term anticoagulation control in children: reply to a rebuttal
Michael Ernest Nesheim (February 5, 1945 – June 4, 2011)
Join ISTH